Select Page
White Paper

How The NMPA Is Changing The Chinese Pharmaceutical Industry

cover

    Please fill in the form in order to get this document in your email inbox.
    We value your privacy and will never share your data with third parties.

    Since 2015, the NMPA (CFDA) has initiated a series of reform documents, with the purpose of pushing the Chinese pharmaceutical and medical device industry to a more mature and globalized environment.

     

    Back to White Papers